No retraction, correction or concern found when last checked on Nov 1, 2026.
Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer
J Geisler, N King, M Dowsett and 5 more
British Journal of Cancer · 1996 · Randomised trial
Cited by papers we hold 3
- Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021 · 2022No notice
- Effects of Age on the Detection and Management of Breast Cancer · 2015No notice
- The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer · 2007No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.